These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 26059720)

  • 21. The autoinflammatory diseases: a fashion with blurred boundaries!
    Sarrabay G; Barat-Houari M; Annakib S; Touitou I
    Semin Immunopathol; 2015 Jul; 37(4):359-62. PubMed ID: 25998913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What do autoinflammatory syndromes teach about common cutaneous diseases such as pyoderma gangrenosum? A commentary.
    Butler D; Shinkai K
    Dermatol Clin; 2013 Jul; 31(3):427-35. PubMed ID: 23827245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of Response to Therapy for Autoimmune/Inflammatory Diseases Using an Activated Macrophage-Targeted Radioimaging Agent.
    Kelderhouse LE; Robins MT; Rosenbalm KE; Hoylman EK; Mahalingam S; Low PS
    Mol Pharm; 2015 Oct; 12(10):3547-55. PubMed ID: 26333010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy of autoinflammatory syndromes.
    Hoffman HM
    J Allergy Clin Immunol; 2009 Dec; 124(6):1129-38; quiz 1139-40. PubMed ID: 20004774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of inflammation with anti-inflammatory cytokines: example in models of auto-immune diseases].
    Bessis N; Fradelizi D; Fournier C; Boissier MC
    C R Seances Soc Biol Fil; 1995; 189(4):579-90. PubMed ID: 8564571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broadening the definition of autoinflammation.
    Masters SL
    Semin Immunopathol; 2015 Jul; 37(4):311-2. PubMed ID: 25994947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biological drugs in the treatment of immunoinflammatory diseases].
    Nielsen OH; Bendtzen K
    Ugeskr Laeger; 2008 Jun; 170(24):2103. PubMed ID: 18565288
    [No Abstract]   [Full Text] [Related]  

  • 28. The burgeoning field of innate immune-mediated disease and autoinflammation.
    Peckham D; Scambler T; Savic S; McDermott MF
    J Pathol; 2017 Jan; 241(2):123-139. PubMed ID: 27682255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoinflammatory syndromes.
    Hashkes PJ; Toker O
    Pediatr Clin North Am; 2012 Apr; 59(2):447-70. PubMed ID: 22560579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pathophysiology of autoinflammatory dermatoses].
    Feldmeyer L; Navarini AA
    Hautarzt; 2020 May; 71(5):333-341. PubMed ID: 32333042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Flavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related Diseases.
    Leyva-López N; Gutierrez-Grijalva EP; Ambriz-Perez DL; Heredia JB
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27294919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysfunction in protein clearance by the proteasome: impact on autoinflammatory diseases.
    Brehm A; Krüger E
    Semin Immunopathol; 2015 Jul; 37(4):323-33. PubMed ID: 25963519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Severe acne in autoinflammatory diseases].
    Faleri S; Feichtner K; Ruzicka T
    Hautarzt; 2016 Nov; 67(11):897-901. PubMed ID: 27448064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutralization of macrophage migration inhibitory factor-novel approach for the treatment of immunoinflammatory disorders.
    Cvetkovic I; Stosic-Grujicic S
    Int Immunopharmacol; 2006 Oct; 6(10):1527-34. PubMed ID: 16919824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Anti-IL-1 Medications in Autoinflammatory Disease.
    Semo-Oz R; Biton B; Tesher MS
    Pediatr Ann; 2022 Feb; 51(2):e72-e76. PubMed ID: 35156883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New therapeutic solutions for Behçet's syndrome.
    Vitale A; Rigante D; Lopalco G; Emmi G; Bianco MT; Galeazzi M; Iannone F; Cantarini L
    Expert Opin Investig Drugs; 2016 Jul; 25(7):827-40. PubMed ID: 27163156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of systemic autoimmune and inflammatory diseases with rituximab].
    Bussone G; Hachulla E; Sibilia J; Michel M; Godeau B; Guillevin L; Mouthon L
    Presse Med; 2009 May; 38(5):808-23. PubMed ID: 19297127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-inflammatory Agents: Present and Future.
    Dinarello CA
    Cell; 2010 Mar; 140(6):935-50. PubMed ID: 20303881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein misfolding and dysregulated protein homeostasis in autoinflammatory diseases and beyond.
    Agyemang AF; Harrison SR; Siegel RM; McDermott MF
    Semin Immunopathol; 2015 Jul; 37(4):335-47. PubMed ID: 25994946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein-kinase inhibitors: A new treatment pathway for autoimmune and inflammatory diseases?
    Hernández-Flórez D; Valor L
    Reumatol Clin; 2016; 12(2):91-9. PubMed ID: 26283525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.